Universe Pharmaceuticals INC
corporate_fare Company Profile
Universe Pharmaceuticals INC (NASDAQ:UPC) is a publicly traded company in the Life Sciences sector. Wiseek monitors UPC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Universe Pharmaceuticals to Acquire Best Praise for $10.75M in Stock, Causing Over 1000% Dilution
- Universe Pharmaceuticals to Acquire 100% of Best Praise International
- CEO Gang Lai Discloses 13.58% Beneficial Ownership in Universe Pharmaceuticals
- CEO Granted 84,500 Shares, Resulting in 15% Dilution and 75% Voting Control
- Universe Pharmaceuticals Adopts Highly Dilutive 2026 Equity Incentive Plan
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for UPC, detected from its recent SEC filings · based on capital-structure filings through 2026-05-14.
Significant Share Grant to CEO · Material Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
UPC files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.